Does tibolone exacerbate atherosclerosis?

European Heart Journal

Volumn 27, Issue 6, 2006, Pages 635-637

  Clarkson, Thomas B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; LIPID; LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CLINICAL TRIAL; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; EDITORIAL; HUMAN; INTIMA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; REMISSION; THICKNESS; TREATMENT OUTCOME;

ATHEROSCLEROSIS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; NORPREGNENES;

EID: 33644916417     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi724     Document Type: Editorial

References (10)

1. Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE. The effect of tibolone and continuous combined conjugated equine estrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tibolone (OPAL) study. Eur Heart J 2006;27:746-755. First published on January 16, 2006, doi:10.1093/eurheartj/ehi695.
2. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol 1990;75:217-222.
3. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-1057.
4. Karim R, Mack WJ, Lobo RA, Hwang J, Liu C, Liu C, Sevanian A, Hodis HN. Determinants of the effect of estrogen on the progression of subclincal atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005;12:366-373.
5. Clarkson TB, Anthony MS, Wagner JD. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 2001;86:5396-5404.
6. Mikkola TS, Anthony MS, Clarkson TB, St Clair RW. Serum cholesterol efflux in postmenopausal monkeys treated with tibolone or conjugated estrogens. Metabolism 2002;51:523-530.
7. von Eckardstein A, Schmiddem K, Hövels A, Gulbahce E, Schuler-Luttmann S, Elbers J, Helmond F, Bennink HJ, Assmann G. Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity. Atherosclerosis 2001;159:433-439.
8. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu C, Liu C, Azen SP. Estrogen in the prevention of atherosclerosis. Ann Intern Med 2001;135:939-953.
9. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 1995;142:1011-1019.
10. Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, Riley W, Craven T, Chaput L, Ireland CC, Applegate WB. Effect of estrogen plus progestin on progression of carotid atherosclosis in postmenopausal women with heart disease. Arterioscler Thromb Vasc Biol 2002;22:1692-1697.